Autologous CAR-T Cell Manufacturing: Current Standing and Future Directions
A Look at What Drug Manufacturers are Likely Using to Make CAR-T Products
Supplement: MilliporeSigma Sees Opportunity in Continuous Processing
From the GEN Sounds of Science Podcast
Why CAR-T Therapies Don’t Work for Everyone Yet
Selecting the Best Type of T Cells for CAR-T May be Key to the Overall Efficacy of the Therapies
Cell-Centered: Scientists Embrace Cell-Replacement Therapy for Type 1 Diabetes
Forming Beta Cells from Stem Cells
For full access to this article login to GEN Select now.
Purification Methods in Biomanufacturing
Existing Techniques Must Be Revamped in Order to Deliver as Much Product as Possible
- The biomanufacturing industry as we know it today emerged in the 1980s following the unprecedented early success of recombinant DNA technology. The approach was launched onto an unsuspecting and unprepared market in 1976 by the founders of Genentech. They pioneered the expression of somatostatin in bacteria (the first ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.